GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alpha Tau Medical Ltd (NAS:DRTS) » Definitions » Cash-to-Debt

Alpha Tau Medical (Alpha Tau Medical) Cash-to-Debt : 5.99 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Alpha Tau Medical Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Alpha Tau Medical's cash to debt ratio for the quarter that ended in Mar. 2024 was 5.99.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Alpha Tau Medical could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Alpha Tau Medical's Cash-to-Debt or its related term are showing as below:

DRTS' s Cash-to-Debt Range Over the Past 10 Years
Min: 5.99   Med: No Debt   Max: No Debt
Current: 5.99

During the past 5 years, Alpha Tau Medical's highest Cash to Debt Ratio was No Debt. The lowest was 5.99. And the median was No Debt.

DRTS's Cash-to-Debt is ranked worse than
52.12% of 1489 companies
in the Biotechnology industry
Industry Median: 6.91 vs DRTS: 5.99

Alpha Tau Medical Cash-to-Debt Historical Data

The historical data trend for Alpha Tau Medical's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Alpha Tau Medical Cash-to-Debt Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
No Debt No Debt No Debt 20.13 6.16

Alpha Tau Medical Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.46 14.90 14.41 6.16 5.99

Competitive Comparison of Alpha Tau Medical's Cash-to-Debt

For the Biotechnology subindustry, Alpha Tau Medical's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alpha Tau Medical's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alpha Tau Medical's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Alpha Tau Medical's Cash-to-Debt falls into.



Alpha Tau Medical Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Alpha Tau Medical's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Alpha Tau Medical's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alpha Tau Medical  (NAS:DRTS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Alpha Tau Medical Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Alpha Tau Medical's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Alpha Tau Medical (Alpha Tau Medical) Business Description

Traded in Other Exchanges
N/A
Address
5 Kiryat Hamada Street, Building B3, 4th Floor, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors.